Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)
CAPS Rating:
A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.
RSS Headlines
Fool UK
Recs
Some great buzz about this company right now. Good clinicals taking place, nice earnings and some great growth potential. I like this for the long term...